bioRxiv · 20 Nov 2026
Spatial single cell multi-omics identifies divergent melanoma-cell states associated with metastatic outcomes in thin primary melanomas
Asier Antoranz, Madhavi Dipak Andhari, Jonathan Chui, Nikolina Dubroja, Pouya Nazari, Niels Vandermeulen, Katy Vandereyken, Jérémie Nsengimana, Canan Güvenç, Philip Georg Demaerel, Delphine Verstegen, Annemiek Leeman, Joanna Pozniak, Daniela Massi, Vincenzo De Giorgi, Anna Szumera-Ciećkiewicz, Piotr Rutkowski, Paweł Teterycz, Antien Mooyaart, Sara Valpione, Veerle Boecxstaens, Thierry Voet, Olivier Govaere, Francesca Bosisio
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Thin melanomas (Breslow thickness [≤]1 mm) generally have favorable outcomes, yet some metastasise, highlighting the need for biomarkers of progression. Here, we combined same-section single-cell spatial transcriptomics and proteomics to identify seven melanoma-cell states organized along two inferred trajectories sharing a common trunk, extending from an in situ epithelial-adjacent state through developmental stress to melanocytic differentiation before diverging into two lineages. Lineage 1 progressed through an IFN-associated stress intermediate state towards mesenchymal-invasive cells enriched in metastasizing tumors and associated with immune-hot neighborhoods, extracellular-matrix remodeling and angiogenesis, potentially supporting vascular mimicry and metastatic dissemination. Lineage 2 terminated in cohesive nevus-like cells retaining melanocytic features within relatively immune-cold neighborhoods and enriched in non-metastasizing tumors. We confirmed these associations using H&E-inferred spatial transcriptomics in an international multicentric cohort and independent bulk transcriptomic datasets in primary melanomas, linking spatially organized melanoma-cell programs to metastatic outcome and identifying potential biomarkers of progression in thin melanoma.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.